Pages that link to "Q36887068"
Jump to navigation
Jump to search
The following pages link to A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody (Q36887068):
Displaying 50 items.
- Transplantation tolerance and its outcome during infections and inflammation (Q26829817) (← links)
- The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection (Q26862195) (← links)
- Role of complement and NK cells in antibody mediated rejection (Q26864255) (← links)
- MHC class I signaling: new functional perspectives for an old molecule (Q27000194) (← links)
- Effector mechanisms of rejection (Q27027082) (← links)
- Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms (Q27314948) (← links)
- Immunosenescence in renal transplantation: a changing balance of innate and adaptive immunity (Q28084018) (← links)
- Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis (Q28084366) (← links)
- The Complement System and Antibody-Mediated Transplant Rejection (Q28087773) (← links)
- The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies (Q30397251) (← links)
- Pros and cons for C4d as a biomarker (Q30544649) (← links)
- Defunctioning polymorphism in the immunoglobulin G inhibitory receptor (FcγRIIB-T/T232) does not impact on kidney transplant or recipient survival (Q34106643) (← links)
- Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. (Q35027253) (← links)
- 3-dimensional digital reconstruction of the murine coronary system for the evaluation of chronic allograft vasculopathy (Q35248538) (← links)
- Class II alloantibody and mortality in simultaneous liver-kidney transplantation (Q35547071) (← links)
- Recent advances in renal transplantation: antibody-mediated rejection takes center stage (Q35659332) (← links)
- Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection (Q35922715) (← links)
- Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific Antibodies (Q36113914) (← links)
- Antibody-mediated rejection of single class I MHC-disparate cardiac allografts (Q36131185) (← links)
- HLA class I: an unexpected role in integrin β4 signaling in endothelial cells (Q36360674) (← links)
- Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival. (Q36514864) (← links)
- Ganciclovir prophylaxis improves late murine cytomegalovirus-induced renal allograft damage (Q36979317) (← links)
- Ischemia-reperfusion injury accelerates human antibody-mediated transplant vasculopathy (Q37044541) (← links)
- Chronic alloantibody mediated rejection (Q37058050) (← links)
- HLA class I antibody-mediated endothelial and smooth muscle cell activation (Q37430871) (← links)
- Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells. (Q37453921) (← links)
- Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. (Q37602004) (← links)
- Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy (Q37660263) (← links)
- Antibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft Injury (Q37720377) (← links)
- Clinical role of the renal transplant biopsy (Q37974480) (← links)
- The impact of donor-specific anti-HLA antibodies on late kidney allograft failure (Q38003049) (← links)
- Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury. (Q38032621) (← links)
- Transplant tolerance: new insights and strategies for long-term allograft acceptance (Q38114067) (← links)
- Lymphodepletional strategies in transplantation. (Q38118743) (← links)
- Innate immune cells in transplantation (Q38169495) (← links)
- Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms. (Q38169496) (← links)
- NK cells after transplantation: friend or foe. (Q38187574) (← links)
- Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy (Q38218005) (← links)
- Complement modulation in solid-organ transplantation. (Q38226479) (← links)
- Evolving perspectives of mTOR complexes in immunity and transplantation (Q38367426) (← links)
- Achieving incompatible transplantation through desensitization: current perspectives and future directions (Q38445336) (← links)
- Currently available useful immunohistochemical markers of renal pathology for the diagnosis of renal allograft rejection (Q38510977) (← links)
- Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy. (Q38544617) (← links)
- Complement inhibition as potential new therapy for antibody-mediated rejection. (Q38609238) (← links)
- Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms (Q38635496) (← links)
- Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts (Q38635500) (← links)
- The Cell Biology of Cytomegalovirus: Implications for Transplantation (Q38779938) (← links)
- Innate immune mechanisms in transplant allograft vasculopathy (Q38808100) (← links)
- mTOR inhibitors and risk of chronic antibody-mediated rejection after kidney transplantation: where are we now? (Q38818479) (← links)
- T Cells Going Innate (Q38893279) (← links)